000 | 01948 a2200577 4500 | ||
---|---|---|---|
005 | 20250513031542.0 | ||
264 | 0 | _c19950413 | |
008 | 199504s 0 0 eng d | ||
022 | _a0006-291X | ||
024 | 7 |
_a10.1006/bbrc.1995.1345 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTsujinaka, T | |
245 | 0 | 0 |
_aAutocatalytic inactivation of lysosomal cathepsins is associated with inhibition of protein breakdown by insulin-like growth factor-1 (IGF-1) in myotubes. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _cMar 1995 |
||
300 |
_a353-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 |
_aCathepsin B _xbiosynthesis |
650 | 0 | 4 | _aCathepsin L |
650 | 0 | 4 |
_aCathepsins _xantagonists & inhibitors |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCystatins _xbiosynthesis |
650 | 0 | 4 | _aCysteine Endopeptidases |
650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aEndopeptidases |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 |
_aInsulin _xpharmacology |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xpharmacology |
650 | 0 | 4 |
_aLeucine _xanalogs & derivatives |
650 | 0 | 4 |
_aLysosomes _xenzymology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMuscle, Skeletal |
650 | 0 | 4 | _aProtein Biosynthesis |
650 | 0 | 4 |
_aProteins _xmetabolism |
650 | 0 | 4 |
_aRNA _xbiosynthesis |
650 | 0 | 4 | _aRats |
700 | 1 | _aEbisui, C | |
700 | 1 | _aFujita, J | |
700 | 1 | _aMorimoto, T | |
700 | 1 | _aOgawa, A | |
700 | 1 | _aIshidoh, K | |
700 | 1 | _aKominami, E | |
700 | 1 | _aYano, M | |
700 | 1 | _aShiozaki, H | |
700 | 1 | _aMonden, M | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 208 _gno. 1 _gp. 353-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.1995.1345 _zAvailable from publisher's website |
999 |
_c7533535 _d7533535 |